BG Medicine, Boston Scientific Study Galectin-3 for CRT

The companies will study the potential role of galectin-3 in screening patients for cardiac-resynchronization therapy.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.